Furthermore, the levels of IL-6 and albumin are independent risk factors for pulmonary fibrosis and should be regarded as important therapeutic targets for the treatment of COVID-19 patients with pulmonary fibrosis. The gene discussed is ALB; the disease is COVID-19.